Literature DB >> 23617254

Causes of visual loss associated with uveitis in a singapore tertiary eye center.

Tun Kuan Yeo1, Su Ling Ho, Wee Kiak Lim, Stephen C Teoh.   

Abstract

PURPOSE: To identify the causes of visual loss associated with uveitis and its risk factors.
METHODS: Review of 359 patients attending a uveitis service.
RESULTS: Anterior uveitis (n = 229, 63.8%) was most common, followed by panuveitis (n = 55, 15.3%). There were 82 infective cases with 29.3% associated with tuberculosis. Visual loss occurred in 100 (27.9%) patients, of which 27 (7.5%) had severe visual loss. The main causes of visual loss were cataract (26%) and glaucoma (12%). Cystoid macular edema (14.8%) accounted for severe visual loss. Panuveitis was predictive for visual loss (p = 0.022, odds ratio (OR) 2.22) and severe visual loss (p = 0.01, OR 3.47). Posterior uveitis (p = 0.005, OR 5.01) and chronic uveitis (p = 0.008, OR 3.83) also showed higher risk for severe visual loss.
CONCLUSION: With panuveitis being the second most common presentation, early specialist referral is essential in preventing visual loss.

Entities:  

Mesh:

Year:  2013        PMID: 23617254     DOI: 10.3109/09273948.2013.774424

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  10 in total

1.  Visual loss in uveitis.

Authors:  N P Jones
Journal:  Eye (Lond)       Date:  2016-06-17       Impact factor: 3.775

2.  Tuberculosis and other causes of uveitis in Indonesia.

Authors:  R La Distia Nora; R Sitompul; M Bakker; M Susiyanti; L Edwar; S Sjamsoe; G Singh; M P van Hagen; A Rothova
Journal:  Eye (Lond)       Date:  2017-11-03       Impact factor: 3.775

3.  The Association between QuantiFERON-TB Gold Test and Clinical Manifestations of Uveitis in the United States.

Authors:  Mehmet Yakin; Natasha Kesav; Shuk Kei Cheng; Sonny Caplash; Sapna Gangaputra; H Nida Sen
Journal:  Am J Ophthalmol       Date:  2021-05-02       Impact factor: 5.488

4.  The role of lipoprotein-associated phospholipase A2 in a murine model of experimental autoimmune uveoretinitis.

Authors:  G L Crawford; J Boldison; D A Copland; P Adamson; D Gale; M Brandt; L B Nicholson; A D Dick
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

5.  Tubercular Uveitis in Uveitis Cases in a High TB and HIV Setting: A Prospective Cohort Study.

Authors:  Hassan D Alli; Naseer Ally; Ismail Mayet; Lavania Joseph; Shaheed V Omar; Shabir A Madhi
Journal:  Transl Vis Sci Technol       Date:  2022-01-03       Impact factor: 3.283

6.  Evaluation of Infectious Uveitis at a Tertiary Referral Center in Turkey: A 31-year Retrospective Study.

Authors:  Hasan Oncul; Caner Kara; Pinar Cakar Ozdal
Journal:  Beyoglu Eye J       Date:  2021-06-08

Review 7.  Recommendation of using systemic anti-tumor necrosis factor-alpha for the treatment of noninfectious uveitis in Taiwan.

Authors:  De-Kuang Hwang; Yih-Shiou Hwang; Ming-Ling Tsai; Chun-Ju Lin; Wei-Chun Chan; Yo-Chen Chang; Der-Yuan Chen; Tsu-Yi Hsieh; Shwu-Jiuan Sheu; Chang-Ping Lin
Journal:  Taiwan J Ophthalmol       Date:  2018 Jul-Sep

8.  Type 1 interferon-inducible gene expression in QuantiFERON Gold TB-positive uveitis: A tool to stratify a high versus low risk of active tuberculosis?

Authors:  Rina La Distia Nora; Ratna Sitompul; Marleen Bakker; Marjan A Versnel; Sigrid M A Swagemakers; Peter J van der Spek; Made Susiyanti; Lukman Edwar; Soedarman Sjamsoe; Gurmeet Singh; Rr Diah Handayani; Aniki Rothova; P Martin van Hagen; Willem A Dik
Journal:  PLoS One       Date:  2018-10-18       Impact factor: 3.240

9.  Involvement of autotaxin in the pathophysiology of elevated intraocular pressure in Posner-Schlossman syndrome.

Authors:  Nozomi Igarashi; Megumi Honjo; Reiko Yamagishi; Makoto Kurano; Yutaka Yatomi; Koji Igarashi; Toshikatsu Kaburaki; Makoto Aihara
Journal:  Sci Rep       Date:  2020-04-14       Impact factor: 4.379

10.  Two-year outcome of Trabeculo-Canalectomy for Chinese Glaucoma Patients.

Authors:  Zhan Xie; Zhao-Xia Mu; Mu-Long Du; Ying-Ting Zhu; Hong Sun
Journal:  Int J Med Sci       Date:  2020-07-25       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.